NCT02731950View on ClinicalTrials.gov

Presternal Bupivacaine Plus Magnesium Sulfate Infusion After Cardiac Surgery

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
PainPostoperative Pain
Interventions
DRUG

Magnesium Sulfate and Bupivacaine 0.125%

Each patient will receive bupivacaine 0.125% with 5% magnesium sulphate by infusion through a catheter used for epidural analgesia, positioned presternal.

Trial Locations (1)

71111

Emad Zarief Kamel Said, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02731950 - Presternal Bupivacaine Plus Magnesium Sulfate Infusion After Cardiac Surgery | Biotech Hunter | Biotech Hunter